181 related articles for article (PubMed ID: 37535157)
1. Deep convolutional neural network for differentiating between sarcoidosis and lymphoma based on [
Aoki H; Miyazaki Y; Anzai T; Yokoyama K; Tsuchiya J; Shirai T; Shibata S; Sakakibara R; Mitsumura T; Honda T; Furusawa H; Okamoto T; Tateishi T; Tamaoka M; Yamamoto M; Takahashi K; Tateishi U; Yamaguchi T
Eur Radiol; 2024 Jan; 34(1):374-383. PubMed ID: 37535157
[TBL] [Abstract][Full Text] [Related]
2.
Sibille L; Seifert R; Avramovic N; Vehren T; Spottiswoode B; Zuehlsdorff S; Schäfers M
Radiology; 2020 Feb; 294(2):445-452. PubMed ID: 31821122
[TBL] [Abstract][Full Text] [Related]
3. (18)F-FDG and (18)F-FLT PET/CT imaging in the characterization of mediastinal lymph nodes.
Rayamajhi SJ; Mittal BR; Maturu VN; Agarwal R; Bal A; Dey P; Shukla J; Gupta D
Ann Nucl Med; 2016 Apr; 30(3):207-16. PubMed ID: 26661845
[TBL] [Abstract][Full Text] [Related]
4. Convolutional neural network-based program to predict lymph node metastasis of non-small cell lung cancer using
Kidera E; Koyasu S; Hirata K; Hamaji M; Nakamoto R; Nakamoto Y
Ann Nucl Med; 2024 Jan; 38(1):71-80. PubMed ID: 37755604
[TBL] [Abstract][Full Text] [Related]
5. Computer-aided diagnostic models to classify lymph node metastasis and lymphoma involvement in enlarged cervical lymph nodes using PET/CT.
Yang Y; Zheng B; Li Y; Li Y; Ma X
Med Phys; 2023 Jan; 50(1):152-162. PubMed ID: 35925871
[TBL] [Abstract][Full Text] [Related]
6. Deep learning for [
Häggström I; Leithner D; Alvén J; Campanella G; Abusamra M; Zhang H; Chhabra S; Beer L; Haug A; Salles G; Raderer M; Staber PB; Becker A; Hricak H; Fuchs TJ; Schöder H; Mayerhoefer ME
Lancet Digit Health; 2024 Feb; 6(2):e114-e125. PubMed ID: 38135556
[TBL] [Abstract][Full Text] [Related]
7. Distinction of Lymphoma from Sarcoidosis on
Lovinfosse P; Ferreira M; Withofs N; Jadoul A; Derwael C; Frix AN; Guiot J; Bernard C; Diep AN; Donneau AF; Lejeune M; Bonnet C; Vos W; Meyer PE; Hustinx R
J Nucl Med; 2022 Dec; 63(12):1933-1940. PubMed ID: 35589406
[TBL] [Abstract][Full Text] [Related]
8. Prediction of Lymph Node Maximum Standardized Uptake Value in Patients With Cancer Using a 3D Convolutional Neural Network: A Proof-of-Concept Study.
Shaish H; Mutasa S; Makkar J; Chang P; Schwartz L; Ahmed F
AJR Am J Roentgenol; 2019 Feb; 212(2):238-244. PubMed ID: 30540209
[TBL] [Abstract][Full Text] [Related]
9. Convolutional Neural Networks in Predicting Nodal and Distant Metastatic Potential of Newly Diagnosed Non-Small Cell Lung Cancer on FDG PET Images.
Tau N; Stundzia A; Yasufuku K; Hussey D; Metser U
AJR Am J Roentgenol; 2020 Jul; 215(1):192-197. PubMed ID: 32348182
[No Abstract] [Full Text] [Related]
10. Diagnostic performance of
Ishiguchi H; Ito S; Kato K; Sakurai Y; Kawai H; Fujita N; Abe S; Narita A; Nishio N; Muramatsu H; Takahashi Y; Naganawa S
Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
[TBL] [Abstract][Full Text] [Related]
11. Validation of Convolutional Neural Networks for Fast Determination of Whole-Body Metabolic Tumor Burden in Pediatric Lymphoma.
Etchebehere E; Andrade R; Camacho M; Lima M; Brink A; Cerci J; Nadel H; Bal C; Rangarajan V; Pfluger T; Kagna O; Alonso O; Begum FK; Mir KB; Magboo VP; Menezes LJ; Paez D; Pascual TN
J Nucl Med Technol; 2022 Sep; 50(3):256-262. PubMed ID: 35440476
[No Abstract] [Full Text] [Related]
12. Machine learning-based diagnostic method of pre-therapeutic
Yoo J; Cheon M; Park YJ; Hyun SH; Zo JI; Um SW; Won HH; Lee KH; Kim BT; Choi JY
Eur Radiol; 2021 Jun; 31(6):4184-4194. PubMed ID: 33241521
[TBL] [Abstract][Full Text] [Related]
13. Clinical features and
Chen D; Zhu Y; Chen Y; Zhu D; Liu Z; Li T; Liu Y; Zhao K; Su X; Li L
BMC Infect Dis; 2022 Jul; 22(1):646. PubMed ID: 35896979
[TBL] [Abstract][Full Text] [Related]
14. Value of 18-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in the differential diagnosis of sarcoidosis and lung cancer with lymph node metastasis: a retrospective study.
Chen X; Xu X; Chrysikos S; Zhao M; Zhou Y
Transl Lung Cancer Res; 2022 Sep; 11(9):1926-1935. PubMed ID: 36248335
[TBL] [Abstract][Full Text] [Related]
15. Dual-Energy CT-Derived Electron Density for Diagnosing Metastatic Mediastinal Lymph Nodes in Non-Small Cell Lung Cancer: Comparison With Conventional CT and FDG PET/CT Findings.
Nagano H; Takumi K; Nakajo M; Fukukura Y; Kumagae Y; Jinguji M; Tani A; Yoshiura T
AJR Am J Roentgenol; 2022 Jan; 218(1):66-74. PubMed ID: 34319164
[No Abstract] [Full Text] [Related]
16. FDG PET/CT radiomics as a tool to differentiate between reactive axillary lymphadenopathy following COVID-19 vaccination and metastatic breast cancer axillary lymphadenopathy: a pilot study.
Eifer M; Pinian H; Klang E; Alhoubani Y; Kanana N; Tau N; Davidson T; Konen E; Catalano OA; Eshet Y; Domachevsky L
Eur Radiol; 2022 Sep; 32(9):5921-5929. PubMed ID: 35385985
[TBL] [Abstract][Full Text] [Related]
17. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
18. Comparison of machine learning methods for classifying mediastinal lymph node metastasis of non-small cell lung cancer from
Wang H; Zhou Z; Li Y; Chen Z; Lu P; Wang W; Liu W; Yu L
EJNMMI Res; 2017 Dec; 7(1):11. PubMed ID: 28130689
[TBL] [Abstract][Full Text] [Related]
19. Is SUVmax Helpful in the Differential Diagnosis of Enlarged Mediastinal Lymph Nodes? A Pilot Study.
Yu C; Xia X; Qin C; Sun X; Zhang Y; Lan X
Contrast Media Mol Imaging; 2018; 2018():3417190. PubMed ID: 30510493
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of diffuse lymphadenopathy via various quantitative PET/CT parameters.
Silov G; Çankaya E; Karaçavuş S
Hell J Nucl Med; 2023; 26(1):47-56. PubMed ID: 37031422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
